UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 738

Sortiert nach

PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction

PLoS computational biology, 2017-03, Vol.13 (3), p.e1005455-e1005455

2017

Volltextzugriff (PDF)

IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer

Journal of cellular and molecular medicine, 2020-12, Vol.24 (23), p.13949-13960

2020

Volltextzugriff (PDF)

Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas

Cancer letters, 2015-03, Vol.358 (2), p.220-231

2015

Volltextzugriff (PDF)

Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer

Theranostics, 2022, Vol.12 (2), p.620-638

2022

Volltextzugriff (PDF)

FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Genome medicine, 2020-09, Vol.12 (1), p.77-27, Article 77

2020

Volltextzugriff (PDF)

CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis

Molecular cancer, 2020-02, Vol.19 (1), p.41-14, Article 41

2020

Volltextzugriff (PDF)

Tumor‐derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines

Cancer science, 2020-12, Vol.111 (12), p.4348-4358

2020

Volltextzugriff (PDF)

CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis

BioMed research international, 2019, Vol.2019, p.1245072-16

2019

Volltextzugriff (PDF)

USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis

Gut, 2020-09, Vol.69 (9), p.1582

2020

Volltextzugriff (PDF)

High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability

BMC cancer, 2021-02, Vol.21 (1), p.186-186, Article 186

2021

Volltextzugriff (PDF)

Tumor mutational burden is associated with poor outcomes in diffuse glioma

BMC cancer, 2020-03, Vol.20 (1), p.213-213, Article 213

2020

Volltextzugriff (PDF)

The extracellular matrix supports breast cancer cell growth under amino acid starvation by promoting tyrosine catabolism

PLoS biology, 2024-01, Vol.22 (1), p.e3002406-e3002406

2024

Volltextzugriff (PDF)

Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20‐CCR6 pathway

Cancer science, 2021-01, Vol.112 (1), p.144-154

2021

Volltextzugriff (PDF)

MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway

Bioscience reports, 2021-12, Vol.41 (12), p.1

2021

Volltextzugriff (PDF)

The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis

BMC cancer, 2020-05, Vol.20 (1), p.471-471, Article 471

2020

Volltextzugriff (PDF)

Cuproptosis identifies respiratory subtype of renal cancer that confers favorable prognosis

Apoptosis (London), 2022-12, Vol.27 (11-12), p.1004-1014

2022

Volltextzugriff (PDF)

Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression

Cancer letters, 2018-08, Vol.428, p.77-89

2018

Volltextzugriff (PDF)

Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis

BMC cancer, 2022-01, Vol.22 (1), p.107-107, Article 107

2022

Volltextzugriff (PDF)

AZD1775 and anti-PD-1 antibody synergistically sensitize hepatoma to radiotherapy

Chinese medical journal, 2024-01, Vol.137 (2), p.222-231

2024

Volltextzugriff (PDF)

OGG1 contributes to hepatocellular carcinoma by promoting cell cycle‐related protein expression and enhancing DNA oxidative damage repair in tumor cells

Journal of clinical laboratory analysis, 2022-07, Vol.36 (7), p.e24561-n/a

2022

Volltextzugriff (PDF)

TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle

BMC cancer, 2023-08, Vol.23 (1), p.716-716, Article 716

2023

Volltextzugriff (PDF)

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer

Cancer cell international, 2019-10, Vol.19 (1), p.264-264, Article 264

2019

Volltextzugriff (PDF)

Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer

eLife, 2019-05, Vol.8

2019

Volltextzugriff (PDF)

microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation

BMC cancer, 2024-01, Vol.24 (1), p.26-26, Article 26

2024

Volltextzugriff (PDF)

New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma

Cancer letters, 2019-04, Vol.446, p.90-102

2019

Volltextzugriff (PDF)

1 – 25 von 738

Suche als RSS-Feed

Aktive Filter

PublikationsformTagungsberichte

ThemaMedical Prognosis

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(639)
Mit Volltextzugriff
(731)

Publikationsform

Artikel
(737)
Newsletter-Artikel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Oncology Letters
(53)
Cancers
(45)
Bmc Cancer
(42)
Cancer Cell International
(38)
Biomed Research International
(35)
Cancer Medicine
(31)
Journal Of Cellular And Molecular Medicine
(30)
Oncology Reports
(29)
Molecular Medicine Reports
(19)
Cells
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction

IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer

Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas

Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer

FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis

Tumor‐derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines

CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis

USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis

High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability

Tumor mutational burden is associated with poor outcomes in diffuse glioma

The extracellular matrix supports breast cancer cell growth under amino acid starvation by promoting tyrosine catabolism

Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20‐CCR6 pathway

MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway

The prognostic value of IDO expression in solid tumors: a systematic review and meta-analysis

Cuproptosis identifies respiratory subtype of renal cancer that confers favorable prognosis

Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression

Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis

AZD1775 and anti-PD-1 antibody synergistically sensitize hepatoma to radiotherapy

OGG1 contributes to hepatocellular carcinoma by promoting cell cycle‐related protein expression and enhancing DNA oxidative damage repair in tumor cells

TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer

Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer

microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation

New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma

Aktive Filter

Suchergebnisse filtern